This suggests that acquisition of these mutations leads to rapid clonal expansion and transformation to AML in a short time frame, a trajectory exemplified in a study by Quiros et al., who employed sensitive variant calling to identify individuals with NPM1 mutations in the United Kingdom Biobank (UKB) (153). The gene discussed is NPM1; the disease is acute myeloid leukemia.